fentaNYL citrate in 0.9% Sodium Chloride Injection recall: Subpotent
fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL…
Why was fentaNYL citrate in 0.9% Sodium Chloride Injection recalled?
Subpotent Drug
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
a) Lots: 148292, exp 11/9/15 and 150610, exp 1/6/16 and b) Lots: 6208, exp 9/16/15 and 6851, exp 1/19/16
- Product
- fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL…
- Recalling firm
- Cantrell Drug Company
- Quantity
- a) 564 syringes and b) 1146 syringes
- Distribution
- Nationwide
- Recall date
- July 13, 2016
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)